NCT00605241View on ClinicalTrials.gov

A Study To Assess The Effects Of A Single Dose Of GSK598809 In Modulating Nicotine Reward

PHASE1CompletedINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

February 25, 2008

Primary Completion Date

March 20, 2009

Study Completion Date

March 20, 2009

Conditions

Substance Dependence

Interventions

DRUG

GSK598809

Drug

Trial Locations (1)

19104

GSK Investigational Site, Philadelphia

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY